HOME › DRUGS › DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
ACTIVE SUBSTANCE / INN

DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Brand name(s): DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
NDA215448
ACTIVE SUBSTANCE
Dolutegravir, Emtricitabine And Tenofovir Alafenamide
REGULATORS
FDA
SPONSORS / MAH
AUROBINDO PHARMA USA
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDENDA215448AUROBINDO PHARMA USANone (Tentative Approval)

FULL INTELLIGENCE ON DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →